Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00398723
Status:
COMPLETED
Last Update Posted:
2011-10-13
First Post:
2006-11-10
Brief Title:
Narrowband UVB Treatment in Patients With Vitiligo
Sponsor:
Mary Sullivan-Whalen
Organization:
Rockefeller University
Study Overview
Official Title:
Effects of Narrowband UVB Phototherapy on Melanocyte Proliferation in Patients With Vitiligo
Status:
COMPLETED
Status Verified Date:
2011-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study offers narrowband UVB light therapy to patients who have 5 of their body involved with vitiligo
The hypothesis is that Narrowband UVB promotes melanocyte proliferation in vitiligo lesions
The hypothesis is that Narrowband UVB promotes melanocyte proliferation in vitiligo lesions
Detailed Description:
All patients will receive phototherapy with narrowband UVB three times a week for six months or a total of 78 treatments 6mm punch skin biopsies 2 will be done prior to starting therapy once during treatment 2 and at the completion of the study 2 Clinical assessments and photography will be done parallel to the skin biopsies Results clinically and histologically will be analyzed
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None